Company / FCF Margin
Syndax Pharmaceuticals Inc FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-187.5%
FY2025
5-year range
-3344.8% / -187.5%
FY2021-FY2025
Trend
+83.8%
vs FY2024
Sector context
#97 of 134
Health Care
What the data says
At -187.5%, Syndax Pharmaceuticals Inc's fcf margin ranks #97 of 134 in the Health Care sector. FCF Margin has increased for 3 consecutive years, from -4529.9% in FY2020 to -187.5% in FY2025.
Based on SEC 10-K filings.
-187.5% in FY2025 with a 5-year CAGR of +4342.4%.
Improved from -3344.8% to -187.5% over the past 4 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +4342.4pp
- 10-Year Change
- -
Sector benchmark
#97 of 134 in Health CareTop 72% of 134This company -187.5% Sector average -637.8%
▼
+70.6% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 83.8% year-over-year.
- Currently 450.3pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -187.5% | +83.8% |
| FY2024 | -1160.9% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -3344.8% | +26.2% |
| FY2020 | -4529.9% | -101.2% |
| FY2019 | -2251.2% | +22.5% |
| FY2018 | -2903.1% | -634.9% |
| FY2017 | -395.1% | +82.8% |
| FY2016 | -2296.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026